Post-translational modifications [35] and epigenetic regulation [36] acutely impact eNOS activity, and dysregulation of these mechanisms compromise eNOS activity and foster the development of cardiovascular diseases. The gene discussed is NOS3; the disease is cardiovascular disorder.